First-in-human safety and immunogenicity investigations of three adjuvanted reduced dose inactivated poliovirus vaccines (IPV-Al SSI) compared to full dose IPV Vaccine SSI when given as a booster vaccination to adolescents with a history of IPV vaccination at 3, 5, 12months and 5years of age.

Vaccine · 2017 · PMC5267481 · PMID 28027810

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Across poliovirus types and vaccination groups our results furthermore showed a trend that subjects with lower pre-vaccination titres exhibited larger titre increases following the booster vaccine, Fig. 2 , Fig. 3 , Fig. 4 .

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.